Net cash provided by operating and investing activities was $9.1 million in the third quarter and net cash used in operating and investing activities was $84.1 million for the first nine months of 2023; quarter-end cash and restricted cash position was $673.1 millionReceived $55 million payment from Bristol Myers Sq.
Prothena Corporation plc: Prothena Reports Third Quarter 2023 Financial Results and Business Highlights finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Daré Bioscience, Inc. , a leader in women s health innovation, today announced that the exclusive license agreement entered into on March 31, 2022 with Organon , a global women s healthcare. | June 30, 2022